Biannual Meeting of the PPA

Slides:



Advertisements
Similar presentations
Na + and Ca 2+ CHANNELOPATHIES Na + channel (NaV1.4) Potassium aggravated myotonia Paramyotonia congenita Hyperkalemia periodic paralysis Hypokalemic periodic.
Advertisements

Brugada’s Syndrome and Sudden Cardiac Death
Understanding PP and treatment of HypoPP Biannual Meeting of the PPA Orlando, FL, 2011 Frank Lehmann-Horn, Senior Research Professor.
Chapter 51 Diuretic Agents
Objectives Review causes and clinical manifestations of severe electrolyte disturbances Outline emergent management of electrolyte disturbances Recognize.
ELECTRICAL ACTIVITY OF THE HEART
Na + and Ca 2+ CHANNELOPATHIES Na + channel (NaV1.4) Potassium aggravated myotonia Paramyotonia congenita Hyperkalemia periodic paralysis Hypokalemic periodic.
Electrical Characteristics of Channelopathies Involving Skeletal Muscle Bob Ruff, M.D., Ph.D. Chief, SCI Service Louis Stokes Cleveland VAMC Barbara E.
Hypokalemic Periodic Paralysis II BME 301 Spring 2008 Dr. Entcheva Group 6.
MİYOPATİLER Prof.Dr.Aytekin Akyüz CÜ Tıp Fak Nöroloji AD.
Hypokalemic Periodic Paralysis Type II: Mutations of the SCN4A Sodium Gene Presenting : Angela Galotti Jim Gettings Hala Mostafa The Rest :Matt Mancuso.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Chapter 18.
Mineralocorticoid Excess Hyperaldostronism. Epidemiology first description of a patient with an aldosterone-producing adrenal adenoma (Conn's syndrome)
Duchenne Muscular Dystrophy
Potassium Disorders Ganesh Shidham, MD Associate Professor of Internal Medicine Division of Nephrology.
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
Diseases of musculoskeletal system
Division of Neurophysiology Frank Lehmann-Horn, Senior Research Professor Periodic Paralysis Association Orlando, 2011 Overview of Periodic Paralysis Genetic.
Diuretics Remove sodium & water
Acid-Base Imbalances. pH< 7.35 acidosis pH > 7.45 alkalosis The body response to acid-base imbalance is called compensation May be complete if brought.
Investigation of Possible Periodic Paralysis (P3)
1-Overview 2-Classification 3-Indiviual drugs 1-Indications of Diuretics. 2-Adverse effects. 3-Mannitol and Carbonic Anhydrase inhibitors.
Myotonic Disorders. Myotonia Definition: A prolonged failure of relaxation with after- discharge on the EMG Features: Requires strong contraction for.
Excitable tissue- cardiac muscle Dr. Shafali Singh.
ALD and Muscular Dystrophy Heather Vandevanter Period 2.
CONTENTS INTRODUCTION RESTING MEMBRANE POTENTIAL ACTION POTENTIAL ION DISTRIBUTION CHARGE DISTRIGUTION VOLTAGE GATED CHANNELS SPECIFIC CHANNELS INVOLVED.
DIURETICS Part 1 Prof. Hanan Hagar Pharmacology Unit.
Duchenne Muscular Dystrophy Jared Rubenstein. What Causes DMD? Caused by a mutation in a gene, called the DMD gene that can be inherited in families in.
Force of Muscle Contraction
DIURETICS Part 1 Prof. Hanan Hagar Pharmacology Department.
Lecture 6 Renal Handling of Potassium, Calcium & Phosphate.
Hyperkalemia Michael Levin, D.O. Medical Resident PGY II P.C.O.M.
DISEASES OF MUSCLE.
HYPOKALEMIA.
Sodium Reabsorption, Diuretics, and Diet Vivek Bhalla, MD Division of Nephrology Stanford University School of Medicine September 14th, 2015.
Drugs Used for Diuresis Chapter 29 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Muscle diseases and disorders
Diuretics and Antihypertensives
1 In the name of God. 2 1-Resting Membrane Potentials 2-Action potential M.Bayat PhD Session 2.
Hyperkalemia Severe: above 6.5 mmol/l carry
Sodium Reabsorption, Diuretics, and Diet Vivek Bhalla, MD Division of Nephrology Stanford University School of Medicine September 14th, 2015.
HYPOKALEMIA mmol/L) ) Potassium Only 2% is found outside the cells and of this only 0.4% of your K+ is found in the plasma. Thus as you can see.
Date:01 December 2015 Time:6:30 – 9:30 pm Location:Emory University Presentation Room 308 Speakers:Dr. John Richardson National DMD Assoc. President Got.
Pharmacology PHL 101 Abdelkader Ashour, Ph.D. 10 th Lecture.
HYPP Hyperkalemic Periodic Paralaysis M. BRANTLEY, LVT.
-Kidney is a major regulator for potassium Homeostasis.
Objectives  To recognize existence of muscle diseases  To differentiate them from other disorders.  To know about various causes of myopathy.  To.
Drugs for Hypertension
Genetics and its relation to neuromuscular diseases
Conditions in Occupational Therapy 5th edition Ben J
MUSCULAR DYSTROPHY B Y : N A Y B E L P E R E Z.
Drugs Used for Diuresis
Drugs Affecting the Cardiovascular System
Muscle Metabolism Dr. Nabil Bashir.
Sodium Channel Inhibitors
Heart Failure - Summary
Potassium-sparing diuretics
Nerve Impulses.
Sodium Homeostasis Sodium is an electrolyte of major importance in the human body. It is necessary for : normal extracellular volume dynamics  Na in ECF.
Nerve Action Potential :2
Cardiac Muscle Physiology
Biological function of inorganic elements
Cardiac Muscle Physiology
Volume 71, Issue 5, Pages (March 2007)
R14del-PLN in Cardiac Function
Action potentials.
Drugs Used for Diuresis
Presentation transcript:

Biannual Meeting of the PPA Orlando, FL, 2011 Understanding PP and treatment of HypoPP Frank Lehmann-Horn, Senior Research Professor

Electrical potentials P of skeletal muscle fibers P-values around -83 mV are most frequent (P1) Second fraction around -60 mV (P2) P is about 1/100 of the voltage of a car battery Distribution frequency % P2 K+ Battery (mV) -90 -80 -70 -60

Muscle strength dependent on resting potential P Muscle fibers Depolarized fibers can´t develop force -55 mV -65 mV -73 mV Simple basis of PP weakness: Many fibers are episodically or permanently in the P2-state -90mV

Hypokalemic Periodic Paralysis (HypoPP) prevalence: 1:100,000; dominant transmission onset of disease: childhood or puberty clinical features: weakness episodes (at younger age) and/or permanent weakness, a progressive myopathy weakness episodes: up to daily for several hours Provocative factors: carbohydrates, sodium, resting periods after exercise, mental stress, cooling, fever, cortisol induce a drop in serum potassium between episodes: blood potassium is normal etiology: voltage sensor mutations (Na+, Ca2+ channels)

HypoPP mutations are situated in S4 only and cause Na+ leak Central pore Calcium or sodium channel situated in the cell membrane II I VSD III IV Due to the membrane leak of the accessory Na+ pore, the resting potential drops to approx. -58 mV at which fibers are paralyzed S4 Accessory Na+ pore along mutant S4

P2-fraction explains full-blown attack 0.07 0.06 0.05 0.04 0.03 P2 0.02 0.01 0.00 -110 -100 -90 -80 -70 -60 -50 Usually strong E /mv m P2-fraction explains full-blown attack P2 Weak after carb-rich meal P1 hypokalemia opens Na+ pore

Periodic paralysis: permanent weakness large P2-fraction explains perma- nent weakness P2 -90 -80 -70 -60 (mV) Does the accessory pore really con- duct Na+? More Na+ in the fibers?

Novel technique: 23Na-MRI IR Control: low muscle Na+i content 1H-T1 1H-T2-STIR 23Na-IR NaCl solution NaCl in agarose HypoPP with permanent weakness: dystrophy, edema and intracellular Na+ accumulation

Therapy: shifting fibers from the P2- to the P1-state (mV) -90 -80 -70 -60 -90 -80 -70 -60 (mV) -90 -80 -70 -60 (mV) permanent weakness (large P2-fraction) Strength improved by K+ and AA or CAI Volunteer

Therapy: reduction of edema and Na+ overload Control HypoPP before treatment during control untreated patient Jurkat-Rott et al. PNAS 2009

Therapy also increases muscle strength after therapy (acetazolamide) before therapy Jurkat-Rott et al. PNAS 2009

Response to an aldosterone antagonist After 6 months of therapy before therapy After 6 months of therapy

Hypothesis: development of muscle dystrophy normal full muscle strength 25 y. CAI, aldosterone Antagonists, K+ triggers 52 y. intracellular Na+ accumulation and edema reversible weakness with years 80 y. fibrosis and fatty replacement irreversible weakness HypoPP family

Drugs which stabilize muscle fibers in the P1 state Potassium (fast & slow release) Carbonic anhydrase inhibitors - Acetazolamide (Diamox) - Diclofenamide (Daranide) Aldosterone antagonists - Spironolactone (Aldactone) Eplerenone (Inspra) Potassium-sparing diuretics Triamterene (Dyrenium) Amiloride (Midamor) Potassium channel opener Retigabine Delayed K-channel blocker - 3,4-diaminopyridine; 3,4-DAP Diet: high-K, low NaCl-salt low carbohydrate At permanent weakness, continuous ingestion is required

Similar MRI results for Duchenne muscular dystrophy as for PP – synergic therapeutical efforts dystrophin deficiency 1:3,500 male births rapid progression of skeletal muscle dystrophy and cardiomyopathy corticoid treatment

T1w STIR DMD boy at age of 7 years: minor degeneration, however: already severe edema and intracelluar Na accumulation ! Na-IR: intracellular Na+ Franzmann

Na accumulation and edema preceed/cause degeneration T1w STIR DMD boy at age of 10 years: moderate degeneration and still severe edema and intracelluar Na accumulation Na accumulation and edema preceed/cause degeneration [Na+] Na-IR: intracellular Na+ Sommer

Thanks to Karin Jurkat-Rott (Ulm), Marc-André Weber (Heidelberg), & Eva Luise Köhler

View from Ulm University of Ulm Munster and the Alpes